Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
Business Wire•22/10/2026•16:05 ET
0
Key Highlights
- ➤Q3 2026 results scheduled for November 5 after market close
- ➤Management conference call begins November 5 at 1:30pm PT / 4:30pm ET
- ➤Pulse Biosciences is developing nPulse technology for atrial fibrillation treatment
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced it will report business updates and financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. Company management will host a corresponding conference call to discuss business updates beginning at 1:30pm PT / 4:30pm ET.
Get started
Create a free account to read the full story.